Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Am J Physiol Cell Physiol 287:C565571 Matschinsky FM (1990) Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes
Studies suggest they can help restore regular menstrual cycles and improve ovarian morphology, offering direct reproductive benefits
According to the UN, the global population of individuals aged 65 years and above is expected to increase from 761 million in 2021 to 1.6 billion by 2050
US$ 28.52
US$ 22.02
US$ 21.34
US$ 29.67
US$ 22.80
US$ 26.94
US$ 28.24
